Search

everythinglearnresearchcommunity

for

Search:↓

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

The FAW-FS algorithm improves depression recognition, and psychological interventions help AGA patients' mental health.

Premature hair graying is caused by genetics, stress, and lifestyle, and affects mental health.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Siddha medicine can effectively treat Alopecia areata, leading to significant hair regrowth.

Upadacitinib may cause hair loss.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Patients need better information about the risks of long-term steroid use.

Cyclosporin doesn't stop hair loss.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Mesotherapy can cause bruises, swelling, and serious complications, so awareness and careful practice are important.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Low-Level Laser Therapy helps heal wounds and regenerate tissue when used correctly.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Early recognition of methotrexate toxicity symptoms is crucial.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Different nail disorders are treated by targeting their specific causes and using appropriate medications or protective measures.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.